Crossmark

Mechanistic Insights into Bergapten by Modulation of Filamin A and GSK3β in STZ Induced Alzheimer’s Disease: An Integrated In Silico, In Vitro and In Vivo Study

Crossref DOI link: https://doi.org/10.1007/s11064-026-04744-4

Published Online: 2026-04-07

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Riaz, Muhammad

Qadir, Halima

Noman, Muhammad

Ahmed, Sagheer

Shah, Fawad Ali

Malik, Muhammad Usman

Bashir, Kashif

Farooq, Umar

Irshad, Nadeem
License Information

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-04-01
More Information

Article History

Received: 5 December 2025

Revised: 7 March 2026

Accepted: 20 March 2026

First Online: 7 April 2026

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: Study was conducted after approval from Bioethics Committee (BEC), of Quaid-i-Azam University Islamabad, 45320, Pakistan, granted authorized No.# BEC-FBS-QAU 2024-601 governed under the ARRIVE guidelines, the National Centre for the Replacement, Refinement and Reduction of Animals in Research.

Document is current

Any future updates will be listed below